Welcome to LookChem.com Sign In|Join Free
  • or
C20H16N4O is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1622845-40-2

Post Buying Request

1622845-40-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1622845-40-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1622845-40-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,2,8,4 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1622845-40:
(9*1)+(8*6)+(7*2)+(6*2)+(5*8)+(4*4)+(3*5)+(2*4)+(1*0)=162
162 % 10 = 2
So 1622845-40-2 is a valid CAS Registry Number.

1622845-40-2Relevant academic research and scientific papers

Rhodium(iii)-catalyzed regioselective C2-amidation of indoles with N-(2,4,6-trichlorobenzoyloxy)amides and its synthetic application to the development of a novel potential PPARγ modulator

Shi, Jingjing,Zhao, Guanguan,Wang, Xiaowei,Xu, H. Eric,Yi, Wei

, p. 6831 - 6836 (2014)

A new and efficient method for the direct regioselective C2-amidation of various functionalized indoles with several N-(2,4,6-trichlorobenzoyloxy)amides via Rh(iii)-catalyzed C-H activation/N-O cleavage/C-N formation using the pyrimidyl group as a readily installable and removable directing group has been developed. With this method, a variety of valuable 2-amido indoles can be easily prepared under mild conditions with broad functional group tolerance and excellent region-/site-specificities. Application of this strategy to the synthesis of target compound 6 as a novel PPARγ modulator was also demonstrated. The results from biological evaluation showed that compound 6 had a partial PPARγ agonistic activity and a strong PPARγ binding affinity with an IC50 value of 120.0 nM, along with a less pronounced adipocyte differentiation ability compared to the currently marketed anti-diabetic drug rosiglitazone, suggesting that further development of such a compound might be of great interest. This journal is the Partner Organisations 2014.

Iridium(III)-Catalyzed Regioselective Carbenoid Insertion C–H Alkylation by α-Diazotized Meldrum's Acid

Lv, Honggui,Xu, William L.,Lin, Kunhua,Shi, Jingjing,Yi, Wei

supporting information, p. 5637 - 5641 (2016/12/14)

A practical and straightforward protocol for IrIII-catalyzed regioselective carbenoid insertion C–H alkylation mediated by α-diazotized Meldrum's acid was developed. The assistance of external additives and oxidants was not needed, and the developed IrIIIcatalysis proceeds in a highly efficient manner (e.g., mild reaction conditions, short reaction times and excellent regioselectivity) and demonstrates good compatibility with several privileged substrates, such as valuable N-(2-pyrimidyl)indoles, phenylpyridines, and the marketed drug edaravone and its analogues, and thus provides a good complement to previous methods for the rapid construction of the corresponding alkylated products.

Rhodium(iii)-catalyzed C2-selective carbenoid functionalization and subsequent C7-alkenylation of indoles

Shi, Jingjing,Yan, Yunnan,Li, Qiu,Xu, H. Eric,Yi, Wei

supporting information, p. 6483 - 6486 (2014/06/09)

Here a new, mild and versatile method for efficient synthesis of a diverse range of 2-acetate substituted indoles via Rh(iii)-catalyzed and alcohol-mediated C2-selective carbenoid insertion functionalization of indoles by α-diazotized Meldrum's acid has been developed. Furthermore, for the first time, a Rh(iii)/Cu(ii)-catalyzed direct C7-alkenylation of such functionalized products has also been demonstrated. This journal is the Partner Organisations 2014.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1622845-40-2